AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 1.910
0.00 (0.00%)
Jun 18, 2026, 11:55 AM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 2.34 billion as of June 17, 2026. Its market cap has decreased by -48.52% in one year.
Market Cap
2.34B
Enterprise Value
4.10B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.91
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 2.34B, a decrease of -88.38%. That is a compound annual growth rate of -44.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.34B | -40.50% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Boan Biotechnology | 3.11B |
| Jiangsu Recbio Technology | 2.97B |
| PegBio | 2.87B |
| BioDlink International Company | 2.79B |
| TYK Medicines | 2.65B |
| Viva Biotech Holdings | 2.52B |
| Beijing Luzhu Biotechnology | 2.46B |
| Antengene Corporation | 2.42B |